cently, the Committee on the Elimination of Tuberculosis in the United States and on the Committee on Immunization Safety Review. He is author of numerous articles on ethical issues posed by AIDS and tuberculosis, including Private Acts, Social Consequences: AIDS and the Politics of Public Health, and Blood Feuds: AIDS, Blood, and the Politics of Medical Disaster. His most recent co-authored book is AIDS Doctors: Voices from the Epidemic. Dr. Bayer received his Ph.D. in political sciences from the University of Chicago.

Eric Bing, M.D., Ph.D., M.P.H., is the Director of the Center for AIDS Research, Education and Services at Drew University of Medicine and Sciences (Drew CARES), the Director of the Drew Collaborative Alcohol Research Center, and the co-director of the UCLA Center for HIV Identification, Prevention and Treatment Services (CHIPTS). Dr. Bing is a psychiatrist and epidemiologist with extensive expertise in HIV disease. Dr. Bing received his M.D. from Harvard Medical School and his Ph.D. in Epidemiology from UCLA. Following his training in psychiatry, he completed 6 years of training in health services research, initially as a Robert Woods Johnson Clinical Scholar and then as a Scholar in the UCLA Faculty Scholars Program. Dr. Bing’s research primarily focuses on developing and evaluating interventions to improve health care and health outcomes for disadvantaged populations, particularly those affected by HIV, mental illness, and/or alcohol and drug problems. In addition to Dr. Bing’s research programs, he also directs an HIV social services center, which has programs in mental health, case management, treatment education, and peer support.

Samuel A. Bozzette, M.D., Ph.D., an internist and infectious diseases physician, is Professor of Medicine at the University of California San Diego, Chief of the Health Services Research Section at the VA San Diego, and a Senior Natural Scientist at RAND Health. Dr. Bozzette, an author of over 125 scientific publications and reports, has worked extensively in clinical trials of new drug treatments and in bringing comprehensive outcome assessment into trials. He now works on several facets of clinical epidemiology, medical care, outcomes, quality measurement and improvement, and cost. He is a Principal Investigator for the HIV Cost and Services Utilization Study at RAND, and directs both the Center for Research in Patient-Oriented Care at the VA San Diego and the VA’s national Quality Enhancement Research Initiative (QUERI) for HIV/AIDS. He holds degrees from Georgetown University (B.S.), the University of Rochester (M.D.), and the RAND Graduate School of Policy Studies (M.Phil., Ph.D.; Policy Analysis).

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement